Old Web
English
Sign In
Acemap
>
authorDetail
>
Haruhiko Uchikawa
Haruhiko Uchikawa
Shire plc
Immunology
Recombinant factor viii
Diabetes mellitus
Internal medicine
Medicine
3
Papers
11
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Correction to: Inhibitor development, safety, and efficacy of Advate® in previously untreated patients with hemophilia A in a postmarketing surveillance in Japan
2019
International Journal of Hematology
Masashi Taki
Katsuyuki Fukutake
Tadashi Matsushita
Keiji Nogami
Midori Shima
Akira Yoshioka
Junki Takamatsu
Morio Arai
Hiroshi Takagi
Haruhiko Uchikawa
Werner Engl
Akira Shirahata
Show All
Source
Cite
Save
Citations (6)
Perioperative safety and hemostatic efficacy of Advate® in patients with hemophilia A in a postmarketing surveillance in Japan
2018
International Journal of Hematology
Keiji Nogami
H. Takedani
Midori Shima
Akira Yoshioka
Tadashi Matsushita
Junki Takamatsu
Masashi Taki
Katsuyuki Fukutake
Haruhiko Uchikawa
Hiroshi Takagi
Morio Arai
Werner Engl
Akira Shirahata
Show All
Source
Cite
Save
Citations (1)
Efficacy and safety of full-length pegylated recombinant factor VIII with extended half-life in previously treated patients with hemophilia A: comparison of data between the general and Japanese study populations
2017
International Journal of Hematology
Keiji Nogami
Midori Shima
Katsuyuki Fukutake
Teruhisa Fujii
Masashi Taki
Tadashi Matsushita
Satoshi Higasa
Tetsuji Sato
Michio Sakai
Morio Arai
Haruhiko Uchikawa
Werner Engl
Brigitt E. Abbuehl
Barbara A. Konkle
Show All
Source
Cite
Save
Citations (4)
1